NCT03359226View on ClinicalTrials.gov

Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Parkinson Disease
Interventions
PROCEDURE

Submandibular gland biopsy

Needle biopsies of the right and left submandibular glands

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03359226 - Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease | Biotech Hunter | Biotech Hunter